| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 14 |
| 1 | ETANERCEPT | 11 |
| 2 | TADALAFIL | 3 |
| 3 | APREMILAST | 2 |
| 4 | ASPIRIN | 2 |
| 5 | ASPIRIN 325 MG | 2 |
| 6 | ASPIRIN 81 MG | 2 |
| 7 | GUSELKUMAB | 2 |
| 8 | TOFACITINIB | 2 |
| 9 | ACETAMINOPHEN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 1 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 2 | PENTOSAN POLYSULFATE SODIUM | 1 | 0.0001 |
| 3 | VONOPRAZAN FUMARATE | 1 | 0.0001 |
| 4 | PITAVASTATIN CALCIUM | 1 | 0.0001 |
| 5 | ROMOSOZUMAB-AQQG | 1 | 0.0001 |
| 6 | LINAGLIPTIN | 1 | 0.0001 |
| 7 | GUSELKUMAB | 2 | 0.0001 |
| 8 | SOFOSBUVIR | 1 | 0.0001 |
| 9 | BELIMUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anticholinergic [EPC] | 1 | 0.0001 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 4 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 5 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 8 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Phosphodiesterase 4 Inhibitor [EPC] | 2 | 0.0000 |